Antimonium Tartaricum as a Possible Homeopathic Prophylactic Remedy in the COVID-19 Epidemic

Abstract

The current COVID-19 (coronavirus disease 2019) epidemic has proved challenging due to its high impact on physical and mental health. According to Hahnemann, the founder of homeopathy, in an epidemic the most severe symptoms of the clinical condition presented by the population in question should be the basis for selecting the medication that is as similar as possible to them, and which should be administered to individuals who have been exposed to the disease but have not yet developed it. This medicine is called the genus epidemicus. This study aims to demonstrate the reasoning used to propose the homeopathic medicine Antimonium tartaricum (Ant-t) as a genus epidemicus in the COVID-19 epidemic. It was decided to develop the reasoning based on the respiratory symptoms described in the epidemiological bulletins presented by the Health Surveillance Secretariat of the Ministry of Health of Brazil, as these symptoms are the most serious of the disease. After repertorization, it was confirmed in the Materia Medica that Ant-t has a high degree of similarity with these respiratory symptoms, including the most serious situations, of COVID-19. Homeopathic Ant-t is thus a possible prophylactic genus epidemicus in the COVID-19 epidemic; further studies are needed to test this conclusion.

Keywords

COVID-19 - homeopathy - prophylaxis - Antimonium tartaricum

• References

• 1 World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 . Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
• 2 Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91-98
• 3 Hahnemann S. Causa e prevenção da cólera asiática. In: Dudgeon RE. ed. Escritos menores de Samuel Hahnemann. São Paulo: Organon; 2006: 717-720
• 4 Hahnemann S. Materia Medica Pura. New Delhi: Jain Publishers; 2002
• 5 Hahnemann S. Cura e prevenção da febre escarlate. In: Dudgeon RE. ed. Escritos menores de Samuel Hahnemann. São Paulo: Organon; 2006: 351-365
• 6 Hahnemann S. Sobre o tratamento da púrpura miliar. In: Dudgeon RE. ed. Escritos menores de Samuel Hahnemann. São Paulo: Organon; 2006: 661-662
• 7 Hahnemann S. Tratamento do tifo ou febre hospitalar que predomina no momento. In: Dudgeon RE. ed. Escritos menores de Samuel Hahnemann. São Paulo: Organon; 2006: 597-600
• 8 Galhardo JER. História da Homeopatia no Brasil. In: Livro do 1° Congresso Brasileiro de Homeopatia. Rio de Janeiro: Instituto Hahnemanniano do Brasil; 1928: 271-1016
• 9 Teixeira MZ. Homeopatia nas doenças epidêmicas: conceitos, evidências e propostas. Revista de Homeopatia 2010; 73: 36-56
• 10 Daruiche PSJ. Homeopatia nas epidemias: Estudo de caso com base em experiências recentes [Ms dissertation]. São Paulo: Universidade Federal de São Paulo, Escola Paulista de Medicina; 2012
• 11 Teixeira MZ. Fundamentação imunológica da teoria homeopática das vacinoses. Revista de Homeopatia 2003; 68: 29-46
• 12 Castro D, Nogueira GWG. Uso do nosódio Meningococcinum como preventivo contra a meningite meningocócica. In: Castro D. ed. São Paulo: Homeopatia e Profilaxia; 1980: 6-14
• 13 Hahnemann S. Exposição da doutrina homeopática ou Organon da arte de curar. 7th ed.. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2019
• 14 Brasil, Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. Política Nacional de Práticas Integrativas e Complementares no SUS-PNPIC-SUS. 2nd ed.. Brasília: 2015. . Accessed May 6, 2020 at: https://bvsms.saude.gov.br/bvs/publicacoes/politica_nacional_praticas_integrativas_complementares_2ed.pdf
• 15 Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde, Centro de Operações de Emergências em Saúde Pública (COE) COVID-19. Boletim Epidemiológico COVID-19. 2020 Accessed March 30, 2020 at: https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/chamadas/boletim_epidemiolgico_04_coe_covid-19_1583359129.pdf
• 16 Hahnemann S. The Chronic Diseases: Their Peculiar Nature & Their Homeopathic Cure. New Delhi: Jain Publishers; 2005
• 17 Kent JT. Matéria Médica. Rio de Janeiro: Luz Menescal; 2002
• 18 Hering C. Condensed Materia Medica. 4th ed.. New Delhi: Jain Publishers; 2005
• 19 Boger CM. Boenninghausen's Characteristics Materia Medica and Repertory. New Delhi: Jain Publishers; 2002
• 20 Boger CM. A Synoptic Key of the Materia Medica. 5th ed.. New Delhi: Jain Publishers; 2016
• 21 Vijvovsky B. Tratado de Matéria Médica Homeopática. São Paulo: Editora Organon; 2003
• 22 Lathoud JA. Estudos de matéria médica homeopática. 2nd ed.. São Paulo: Organon; 2004
• 23 Allen TF. The Encyclopedia of Pure Materia Medica. New Delhi: Jain Publishers; 2005
• 24 Gupta A, Madhavan MV, Sehgal K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017-1032
• 25 Pan L, Mu M, Yang P. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol 2020; 115: 766-773
• 26 Kent JT. Repertory of the Homeopathic Materia Medica. New Delhi: Jain Publishers; 2005
• 27 World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, March 20, 2020. Accessed May 6, 2020 at: https://apps.who.int/iris/handle/10665/331506